ISRCTN17452402
Completed
未知
Randomised controlled trial to assess the clinical- and cost-effectiveness of physiotherapy and occupational therapy in Parkinson's disease
niversity of Birmingham (UK)0 sites750 target enrollmentSeptember 1, 2008
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Parkinson's disease
- Sponsor
- niversity of Birmingham (UK)
- Enrollment
- 750
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Both males and females, no age limit
- •2\. Idiopathic PD defined by the UK Parkinson's Disease Society Brain Bank Criteria. These criteria are in standard use throughout the NHS in the UK and were supported by the NICE guidelines.
- •3\. PD patients who report limitations in activities of daily living (ADL). We will stratify patients according to their baseline Nottingham Extended Activities of Daily Living (NEADL) score which means we will be able to examine the efficacy of these interventions at different levels of ADL disability.
Exclusion Criteria
- •Current information as of 02/09/2009:
- •1\. Dementia, as usually defined clinically by the patient's physician. From our experience in another trial, some patients with moderate to severe dementia have difficulty in completing self\-assessment forms.
- •2\. Received occupational therapy or physiotherapy in the last 1 year
- •Initial information at time of registration:
- •1\. Dementia, as usually defined clinically by the patient's physician. From our experience in another trial, some patients with moderate to severe dementia have difficulty in completing self\-assessment forms.
- •2\. Received occupational therapy in the last 2 years or physiotherapy in the last 1 year
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
To study the effect of ayurvedic formulation in sciaticaHealth Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhereCTRI/2024/07/071306Dr Aishwarya ghatage
Completed
Not Applicable
Clinical trial of APMV2020 in Covid 19 subjectsCTRI/2021/06/034254Meyer Organics Pvt Ltd320
Not yet recruiting
Phase 3
Clinical trial of Tagar Tablet in Hypertension.Health Condition 1: I10- Essential (primary) hypertensionCTRI/2024/03/064721Dr Vidya Rajendra Jatti
Recruiting
Not Applicable
Randomized controlled clinical study to assess the clinical efficacy of the 3M* Coban* 2 Layer Compression System compared to a short-stretch compression bandage in the treatment fo venous leg ulcerstreatment of venous leg ulcer1004704310057165NL-OMON310993M Deutschland GmbH, Medical Markets Laboratory60
Not yet recruiting
Not Applicable
Randomized controlled clinical study to evaluate a web application (App) to manage and optimize medicatioT78K71K74I12.0I13N18N14I10E78I25E11I50E14Y57.9Adverse effects, not elsewhere classifiedToxic liver diseaseFibrosis and cirrhosis of liverHypertensive renal disease with renal failureHypertensive heart and renal diseaseChronic kidney diseaseDrug- and heavy-metal-induced tubulo-interstitial and tubular conditionsEssential (primary) hypertensionDisorders of lipoprotein metabolism and other lipidaemiasChronic ischaemic heart diseaseType 2 diabetes mellitusHeart failureUnspecified diabetes mellitusDrug or medicament, unspecifiedDRKS00027175Charité Campus Virchow-Klinikum128